AVE Science&Technology CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2022
April 27, 2022 at 04:53 am EDT
Share
AVE Science&Technology CO.,LTD reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 46.08 million compared to CNY 47.24 million a year ago. Revenue was CNY 46.08 million compared to CNY 47.24 million a year ago. Net income was CNY 5.84 million compared to CNY 6.57 million a year ago. Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.13 a year ago. Diluted earnings per share from continuing operations was CNY 0.09 compared to CNY 0.13 a year ago.
AVE Science & Technology Co Ltd is a China-based company principally engaged in the research and development, production, sales and service of medical clinical laboratory analysis instruments and supporting in vitro diagnostic reagents and medical consumables. The Companyâs main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables and other products. The Company's products are mainly used in inspection departments of various medical and health institutions. The Company distributes its products both in the domestic market and to overseas markets.
AVE SCIENCE&TECHNOLOGY CO.,LTD 
